Neuland is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs for over three decades. We provide solutions across the full range of the pharmaceutical industry’s chemistry requirements, from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life cycle, as well as commercial launch. Our strength is our expertise in manufacturing of APIs and advanced intermediates from our US FDA approved facilities. The company has a stellar track record of successful regulatory inspections from the U.S. Food and Drug Administration, PMDA-Japan, EDQM, EMA, KFDA, TGA, ANVISA Brazil and AFSSAPS (France). Neuland is reliable manufacturing and development partner to customers in over 80 countries across US, Europe, Japan, APAC, India, MENA and LATAM.